Albuquerque, NM, United States of America

Wei Wang

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: The University of New Mexico. Active years: 2011-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Wang. Retrieved from https://idiyas.com/inventor/wei-wang-1uah5frt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011-2021

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Wei Wang

Introduction

Wei Wang is a prominent inventor based in Albuquerque, NM (US). He has made significant contributions to the field of cellular function and cancer treatment through his innovative patents. With a total of 4 patents, his work reflects a commitment to advancing medical science and improving therapeutic methods.

Latest Patents

Wei Wang's latest patents include groundbreaking inventions that focus on controlling cellular function and cancer treatment. One of his notable patents is titled "Compositions and methods for controlling cellular function." This disclosure describes compositions and methods that involve a first modular component and a second modular component. The first modular component includes a first target molecule coupled to a first dimerizing moiety, while the second modular component includes a second target molecule coupled to a second dimerizing moiety. The first dimerizing moiety dimerizes with the second dimerizing moiety when the first dimerizing moiety binds a chemical induced proximity (CIP) inducer.

Another significant patent is "Bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer." This invention relates to novel cancer treatment compositions and associated therapeutic methods. More particularly, it involves small chemical bifunctional inhibitors of DNA replication and repair proteins Metnase and/or Intnase that simultaneously damage DNA. The therapeutic method utilizes these inhibitors to enhance the effectiveness of cancer treatment protocols, including radiation therapy.

Career Highlights

Wei Wang is affiliated with the University of New Mexico, where he conducts research and develops innovative solutions in the field of medicine. His work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.

Collaborations

Wei Wang collaborates with esteemed colleagues, including Fu-Sen Liang and Robert A Hromas. These partnerships enhance the research and development of his innovative ideas, contributing to the advancement of medical science.

Conclusion

Wei Wang's contributions to the fields of cellular function and cancer treatment through his patents demonstrate his dedication to innovation and improving healthcare. His work continues to inspire advancements in medical research and therapeutic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…